121 related articles for article (PubMed ID: 9594260)
1. Antiganglioside antibodies in cerebrospinal fluid of children with neuropsychiatric lupus erythematosus.
Chen Y; Wu F; Hou L; Ma S; He X
Chin Med J (Engl); 1997 Aug; 110(8):594-7. PubMed ID: 9594260
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
Kelly MC; Denburg JA
J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
[TBL] [Abstract][Full Text] [Related]
3. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Pereira RM; Yoshinari NH; De Oliveira RM; Cossermelli W
Lupus; 1992 May; 1(3):175-9. PubMed ID: 1301978
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against gangliosides in patients with SLE and neurological manifestations.
Martinez X; Tintoré M; Montalbán J; Ordi J; Vilardell M; Codina A
Lupus; 1992 Oct; 1(5):299-302. PubMed ID: 1303222
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
Hirohata S; Hirose S; Miyamoto T
Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
[TBL] [Abstract][Full Text] [Related]
7. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
8. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.
Martínez-Cordero E; Rivera García BE; Aguilar León DE
J Investig Allergol Clin Immunol; 1997; 7(6):596-601. PubMed ID: 9491201
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.
West SG; Emlen W; Wener MH; Kotzin BL
Am J Med; 1995 Aug; 99(2):153-63. PubMed ID: 7625420
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
13. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.
Labrador-Horrillo M; Martinez-Valle F; Gallardo E; Rojas-Garcia R; Ordi-Ros J; Vilardell M
Lupus; 2012 May; 21(6):611-5. PubMed ID: 22323340
[TBL] [Abstract][Full Text] [Related]
14. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
Hirohata S; Miyamoto T
J Rheumatol; 1986 Aug; 13(4):715-21. PubMed ID: 3095548
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
Zhang C; Shen K; Jiang Z; He X
Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
[TBL] [Abstract][Full Text] [Related]
17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
18. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
19. Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations.
Vogelgesang SA; Heyes MP; West SG; Salazar AM; Sfikakis PP; Lipnick RN; Klipple GL; Tsokos GC
J Rheumatol; 1996 May; 23(5):850-5. PubMed ID: 8724297
[TBL] [Abstract][Full Text] [Related]
20. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
